Markets Brace for Flat Open Amid US Tariff Threats, Pharma Sector in Focus
Indian equities are poised for a flat to mildly negative opening as Gift Nifty trades at 25,030, marginally above September futures but below October contracts. The market's cautious stance reflects global unease, compounded by fresh US tariffs targeting $3.6 billion in Indian pharma exports.
Pharma and IT sectors face mounting pressure—first from H-1B visa fee hikes, now from 100% tariffs on patented drug imports. The rupee hits record lows as foreign outflows accelerate, creating Ripple effects across asset classes. "This isn't isolationism, it's surgical protectionism," says Enrich Money CEO Ponmudi R, noting the Trump administration's dual strikes on knowledge sectors.